scholarly article | Q13442814 |
P356 | DOI | 10.1111/PSYG.12281 |
P698 | PubMed publication ID | 28745443 |
P2093 | author name string | Xin Tan | |
Yutaka Sawa | |||
Shigeru Sase | |||
Ena Kawashima | |||
Homaro Yamamoto | |||
P2860 | cites work | Discrimination Between Patients With Alzheimer Disease and Healthy Subjects Using Layer Analysis of Cerebral Blood Flow and Xenon Solubility Coefficient in Xenon-Enhanced Computed Tomography | Q47296558 |
Positron emission tomography in Alzheimer's disease | Q48328045 | ||
Determination of time-course change rate for arterial xenon using the time course of tissue xenon concentration in xenon-enhanced computed tomography | Q48482856 | ||
Quantitative cerebral blood flow calculation method using white matter lambda in xenon CT. | Q48601054 | ||
320-slice CT neuroimaging: initial clinical experience and image quality evaluation | Q48741576 | ||
Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study | Q48852983 | ||
In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography | Q48967711 | ||
Local cerebral blood flow measured by CT after stable xenon inhalation. | Q51875225 | ||
Pulmonary function affects the quantification of rCBF by non-invasive xenon methods. | Q52080139 | ||
A new clinical scale for the staging of dementia. | Q52220854 | ||
Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PETa | Q53295731 | ||
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q24595802 | ||
“Mini-mental state” | Q25938989 | ||
Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease | Q28222197 | ||
The Clinical Dementia Rating (CDR): current version and scoring rules | Q29616280 | ||
Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects | Q33589643 | ||
Dominantly inherited Alzheimer's disease: cerebral glucose metabolism | Q33628634 | ||
Computed tomography dose assessment for a 160 mm wide, 320 detector row, cone beam CT scanner | Q34169763 | ||
Impact of early intervention and disease modification in patients with predementia Alzheimer's disease: a Markov model simulation | Q35454453 | ||
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy | Q36588166 | ||
Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease | Q36814980 | ||
Alzheimer's disease: strategies for disease modification | Q37739810 | ||
Is brain SPECT useful in degenerative dementia diagnosis? | Q37821218 | ||
Discrepancy of xenon concentrations between end-tidal and blood collection methods in xenon-enhanced computed tomographic measurement of cerebral blood flow | Q43556062 | ||
Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type | Q44601832 | ||
P433 | issue | 1 | |
P921 | main subject | cerebral blood flow | Q5064096 |
Alzheimer's disease | Q11081 | ||
P304 | page(s) | 3-12 | |
P577 | publication date | 2017-07-26 | |
P1433 | published in | Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society | Q27020360 |
P1476 | title | Discrimination between patients with mild Alzheimer's disease and healthy subjects based on cerebral blood flow images of the lateral views in xenon-enhanced computed tomography | |
P478 | volume | 18 |
Q58599968 | Role of GTPases in the Regulation of Mitochondrial Dynamics in Alzheimer's Disease and CNS-Related Disorders | cites work | P2860 |
Search more.